Improving outcomes in early prostate cancer: Part I--adjuvant treatment.
Mazhar
Danish
D
Department of Cancer Medicine, Division of Medicine, Faculty of Medicine, Imperial College London, London, UK.
Ngan
Sarah
S
Waxman
Jonathan
J
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy / Q000379:methods; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D011468:Prostatectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment
D018931:Antineoplastic Agents, Hormonal